Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Sep 29, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 20
- Market value to sell
- $13.6M
- Sellers
- 8
- Companies
- 1
- Under 10b5-1 plans
- 16
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | Jul 2, 20264:31 PM ET | Jeff KnightOfficer | 47.4K | $1.83M | Jul 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Jul 2, 20264:29 PM ET | Rogerio Vivaldi CoelhoDirector | 6.00K | $232.1K | Jul 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Jun 17, 20264:27 PM ET | Stephanie OkeyDirector | 6.90K | $241.5K | Jun 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | May 4, 20264:26 PM ET | Jeff KnightOfficer | 9.48K | $370.1K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Apr 14, 20264:37 PM ET | Jeff KnightOfficer | 20.9K | $808.0K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Apr 13, 20264:36 PM ET | Jeff KnightOfficer | 4.43K | $174.9K | Apr 13, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Apr 8, 20264:49 PM ET | Jeff KnightOfficer | 85.2K | $3.27M | Apr 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 18, 20264:30 PM ET | Dana PizzutiOfficer | 24.8K | $938.0K | Mar 18, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 16, 20269:24 AM ET | Jeff KnightOfficer | 25.1K | $941.5K | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 16, 20269:23 AM ET | Stephen BetzOfficer | 26.5K | $994.4K | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 16, 20269:23 AM ET | Richard Scott StruthersDirector ยท Officer | 45.0K | $1.69M | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 12, 20264:28 PM ET | Rogerio Vivaldi CoelhoDirector | 5.00K | $184.9K | Mar 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 3, 20264:32 PM ET | Stephanie S OkeyDirector | 3.00K | $122.0K | Mar 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Mar 2, 202610:28 AM ET | Tobin SchilkeOfficer | 6.80K | $280.0K | Mar 2, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Feb 2, 20264:32 PM ET | Dana PizzutiOfficer | 10.0K | $499.4K | Feb 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Jan 5, 20264:43 PM ET | Isabel KalofonosOfficer | 2.50K | $116.8K | Jan 5, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Jan 2, 20264:31 PM ET | Dana PizzutiOfficer | 5.00K | $232.8K | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Dec 1, 20254:37 PM ET | Dana PizzutiOfficer | 5.00K | $227.8K | Dec 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Nov 3, 20254:26 PM ET | Dana PizzutiOfficer | 5.00K | $217.5K | Nov 3, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CRNXCrinetics Pharmaceuticals, Inc. | Oct 1, 20254:30 PM ET | Dana PizzutiOfficer | 5.00K | $208.3K | Oct 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |